US Stocks
/
Ernexa Therapeutics Inc. Share Price

Ernexa Therapeutics Inc. Share Price

NASDAQ: ERNA | Micro Cap
$2.08
-$0.01 (-0.48%) Last updated on 23 Oct, 2026 | 22:00 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ernexa Therapeutics Inc. Stock Performance

Open
$2.08
Prev. Close
$2.10
Circuit Range
N/A
Day Range
$2.08 - $2.08
Year Range
$0.14 - $15.75
Volume
394
Average Traded
$2.08

Ernexa Therapeutics Inc. Share Price Today

As of 29 October 2026, Ernexa Therapeutics Inc.'s share price is $2.08. The stock opened at $2.08, compared to its previous close of $2.10. During today's trading session, Ernexa Therapeutics Inc.'s share price traded between $2.08 and $2.08, with an average price of $2.08. Over the past 52 weeks, the stock has recorded a high of $15.75 and a low of $0.14. In terms of performance, Ernexa Therapeutics Inc.'s share price has risen by 1337.93% over the last six months and is up 11.50% on a year-on-year basis.

Ernexa Therapeutics Inc. Share Price Chart

$2.08$2.08
L
Show Current Price
H

Ernexa Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.15M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.52
Revenue (TTM)
$0.00
Return On Equity (TTM)
-383.53%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-224.19%

Ernexa Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.24-$1.51-$5.51-$4.02
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-21.77%-264.90%27.04%

Ernexa Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.07$0.58$0.00
Net Profit-$24.60-$21.68-$44.56-$14.10
Net Profit MarginN/A-30971.43%-7682.76%N/A
Income ChangeN/A11.87%-105.54%68.36%

About Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.

Ernexa Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.91
$2.08
-35.35%
Sep 2026
$4.53
$3.23
-33.09%
Aug 2026
$3.42
$4.82
+41.76%
Jul 2026
$6.65
$3.40
-49.63%
Jun 2026
$9.44
$6.75
-35.84%
May 2026
$0.15
$10.52
+7,155.17%
Apr 2026
$0.21
$0.14
-27.86%
Mar 2026
$0.29
$0.20
-31.40%
Feb 2026
$1.25
$0.29
-75.98%
Jan 2026
$1.16
$1.22
+0.00%
Dec 2025
$1.28
$1.22
-9.63%
Nov 2025
$1.86
$1.35
-27.81%

ERNA Share Price FAQs

What is Ernexa Therapeutics Inc. share price today?

chevron-up
Ernexa Therapeutics Inc. share price today is $2.08 as on October 23, 2026 at 10:00 pm IST.

What is the 52 week high and 52 week low of Ernexa Therapeutics Inc. stock?

chevron-up
The 52 week high of Ernexa Therapeutics Inc. stock is $15.75, while the 52 week low is $0.14 as of 23 Oct '26.

What is ERNA's market capitalisation today?

chevron-up
ERNA market capitalisation is $13.15M as of October 29, 2026, at 2:11 pm IST.

What is ERNA's net income for the last quarter?

chevron-up
ERNA's net income for the last quarter is -4.02B USD.

What is the 5 year returns of ERNA?

chevron-up
The 5 year returns of ERNA is -99.92% as on 23 Oct '26.

What is the high & low stock price of ERNA today?

chevron-up
ERNA stock price hit a high of $2.08 and low of $2.08 as of 23 Oct '26.

Can I buy ERNA shares in India?

chevron-up
Yes. You can buy ERNA in India by opening an international trading account.